CREO scored 37/100 for growth — blending a 3-year historical track record (60%) with analyst forward estimates (40%). Historical revenue has been declining (-45.8% CAGR), a headwind. Forward: EPS expected to grow 49.0%. Weak growth signals across both historical and forward metrics — a clear area of concern.

Insufficient price history to assess momentum. Score defaulted to neutral (50).

CREO scores 24/100 for profitability, assessed sector-relative on margins and via absolute thresholds for capital efficiency. Gross margin of 47.5% is 6% above the sector average of 45% — broadly in line with peers. The company is currently loss-making with a net margin of -717.5%. FCF conversion of 0% is low — reported earnings may overstate true cash generation. Weak profitability across multiple metrics is a clear area of concern for investors.

CREO received a valuation score of 40/100 using sector-relative scoring. Its Forward P/E of 0.0x is 100% below the sector average of 22x. EV/EBITDA of 12.7x sits 9% below the sector norm of 14x. Overall the stock trades at a premium to sector peers, leaving limited margin of safety.

CREO has a financial solvency risk score of 40/100. This represents moderate leverage that warrants monitoring. Interest coverage of -71.5x is adequate but not comfortable. Debt has changed +87% over the last 3 years. The balance sheet is stable in normal conditions but could face stress in a downturn. Watch coverage ratios and free cash flow trends.

CREO scores 94/100 for operational quality, indicating high operational risk. Key concerns: a negative net margin of -717.5% — the company is loss-making; negative FCF (-565.0% FCF margin) — the business is cash burning; weak capital efficiency with -34.2% Cash ROA; significant margin instability of ±243.9pp over 3 years — the primary risk driver here. These weaknesses make the business vulnerable to cost shocks or revenue shortfalls. Monitor profitability trends closely.

CREO has a volatility risk score of 20/100. This shows low volatility with relatively stable prices. Beta of 0.56 indicates defensive characteristics — it moves less than the market. Lower volatility is well-suited to conservative investors and income-focused portfolios.

CREO has a market cap of £0.1B (Nano Cap), resulting in a size risk score of 80/100. As a smaller company, it faces elevated existential risk. Small and micro-caps have higher failure rates, less diversified revenue, and greater vulnerability to competitive threats or economic shocks. They often lack scale advantages and may struggle to access capital markets during stress. While these companies offer growth potential, investors must accept that a meaningful percentage could fail or suffer permanent capital loss. Diversification is critical when investing at this size.